Your browser doesn't support javascript.
loading
Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer.
Zhou, Xumin; Zou, Libin; Chen, Wenbin; Yang, Taowei; Luo, Junqi; Wu, Kaihui; Shu, Fangpeng; Tan, Xiao; Yang, Yu; Cen, Shengren; Li, Chuanyin; Mao, Xiangming.
Afiliación
  • Zhou X; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, PR China; Department of Pathogen Biology and Experimental Teaching Center of Preventive Medicine, Guangdong Provincial Key Laboratory of Tropical Disease, School of Public Health, Southern Medical University, Gu
  • Zou L; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, PR China.
  • Chen W; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, PR China.
  • Yang T; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, PR China.
  • Luo J; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, PR China.
  • Wu K; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, PR China.
  • Shu F; Department of Urology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, PR China.
  • Tan X; Department of Urology, The First Affiliated Hospital, Southwest Medical University, Luzhou 646000, PR China.
  • Yang Y; Department of Urology, Peking University Shenzhen Hospital, Shenzhen 518036, PR China.
  • Cen S; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, PR China.
  • Li C; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, PR China. Electronic address: li-chuanyin@163.com.
  • Mao X; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, PR China. Electronic address: mxm@smu.edu.cn.
Pharmacol Res ; 164: 105305, 2021 02.
Article en En | MEDLINE | ID: mdl-33197601
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_malaria Asunto principal: Proteína p53 Supresora de Tumor / Neoplasias de la Próstata Resistentes a la Castración / Ferroptosis / Mebendazol / Antihelmínticos / Antineoplásicos Límite: Animals / Humans / Male Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Guam
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_malaria Asunto principal: Proteína p53 Supresora de Tumor / Neoplasias de la Próstata Resistentes a la Castración / Ferroptosis / Mebendazol / Antihelmínticos / Antineoplásicos Límite: Animals / Humans / Male Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Guam